Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Jan 16, 2018
    FDA Division Sends Warning Letter Over Company’s Promotional Materials for Eye Drops
  • Jan 15, 2018
    Company, CEO Settle with FTC Over False Claims for Cancer Side Effect Products
  • Jan 15, 2018
    NAD Decides Five Cases Involving Medical Products
  • Jan 14, 2018
    FDA Indefinitely Postpones Drug and Device Intended Use Revisions
  • Jan 2, 2018
    Cook County Sues Opioid Makers
  • Dec 28, 2017
    N.C. Sues Insys Over Subsys Marketing
  • Dec 22, 2017
    OPDP Issues Third Warning Letter of Year; Second for Exhibit Panels
  • Dec 21, 2017
    BIPI Settles Marketing Concerns with States
  • Dec 20, 2017
    NAD Recommends ‘Natural Tears’ Claims Be Discontinued for Contact Lens Solution
  • Dec 17, 2017
    Five Companies Cited for Breaking ABPI Code
  • More

Good Clinical Practice

  • May 9, 2018
    Female Representation in Heart Trials Mixed
  • May 3, 2018
    ICH Addendum Addresses Modeling and Simulation in Pediatric Clinical Investigations; Updates 2000 Guidance
  • May 3, 2018
    FDA Recommends Sponsors Follow HHS Rules When FDA-Regulated Trials Involve Pregnant Women
  • May 2, 2018
    Survey Finds Few Institutional Trial Registration and Reporting Policies
  • Apr 30, 2018
    EMA Issues Draft Guideline on Vaccine Clinical Evaluation
  • Apr 29, 2018
    FDA Issues Final Guidance on Imaging Standards
  • Apr 27, 2018
    FDA Kicks Off MIDD Pilot Program
  • Apr 27, 2018
    Right-to-Try Law Approved in Wisconsin
  • Apr 26, 2018
    Four Research Groups Sign On to CSDR
  • Apr 26, 2018
    Medical Centers Need To Watch How They Promote Clinical Trials
  • More

U.S. Food Labeling

  • Feb 22,2013
    Report Calls for Labeling Disclosure of Nanomaterials
  • Feb 21,2013
    CSPI Petitions FDA To Revise Nutrition Facts Panel To Reflect Artificial Sweetener Content in Sodas
  • Feb 21,2013
    FDA Delays Allergen Risk Assessment To Give Industry More Response Time
  • Feb 20,2013
    Juice Maker Ordered To Hire Labeling Expert Under Recent Consent Decree
  • Feb 14,2013
    FTC Deal Imposes ‘Alcohol Facts’ Panel On Maker of Four Loko Malt Beverages
  • Jan 28,2013
    Food Safety Proposal Adds Labeling Requirements For Some Small and Low-value Farming Operations
  • Jan 25,2013
    General Mills Settles Suit Over Snack Labels, Pledges Labeling Disclosure, Packaging Changes
  • Jan 25,2013
    FTC Bars POM From Making Unproven Claims, Insists on Two Double-Blinded Clinical Trials
  • Jan 25,2013
    FDA Hails 20-Year Anniversary of Nutrition Facts Box Rule
  • Jan 24,2013
    Study Finds Energy Drink Labels Often Inaccurate, Many Products Contain More Caffeine Than Listed
  • More

FDA Regulation & Enforcement

  • Jan 21, 2021
    Fruit Juice Maker Shut Down Under Terms of Consent Decree After Years of cGMP, HACCP Violations
  • Jan 21, 2021
    Journal Article Scrutinizes Nurse Ambassador Programs
  • Jan 21, 2021
    FTC, FDA Move Against Dozens of Supplement Firms Making False COVID-19 Claims
  • Jan 13, 2021
    Court Shuts Down Supplement Company That Claimed Its Vitamin D Products Could Treat COVID-19
  • Jan 11, 2021
    N.Y. Assembly Bill Aims To Keep Individual Prescribing Data Confidential
  • Jan 7, 2021
    Congress Expands FDA’s Administrative Destruction Authority To Include Imported Medical Devices
  • Jan 7, 2021
    ANPR Issued on USDA’s Oversight of Genetically Engineered Animals
  • Jan 7, 2021
    Petition Seeks Dietary Fiber Consideration for Gum Acacia
  • Jan 7, 2021
    FDA Sets New Food Labeling Uniform Compliance Date
  • Jan 7, 2021
    Supplement Firm Owner Pleads Guilty to Drug Distribution
  • More

Medical Devices

  • Nov 4, 2015
    FDA Suggests Data on Electromagnetic Compatibility That Should Be Included in Premarket Submissions
  • Oct 29, 2015
    Response to ‘Critical to Quality’ Inspections Conducted During Pilot Program Is Positive
  • Oct 20, 2015
    Draft Guidance Offers Recommendations for PMA Supplements Dealing with Manufacturing Site Changes
  • Oct 15, 2015
    Draft Guidance from CDRH Offers Recommendations for Animal Studies Conducted for Medical Devices
  • Oct 14, 2015
    Relator Must Wait for Appeal on Whether Fraud on the FDA Can Lead to False Claims Liability
  • Oct 12, 2015
    CDRH Concerned Review Commitments Are Not Being Kept
  • Oct 8, 2015
    South Dakota-Based Laser Manufacturer Shut Down Following Battle Over FDA’s Authority
  • Oct 7, 2015
    HHS Launches Online Platform To Gather Mobile Medical App Developer Input for HIPAA Privacy Guidance
  • Oct 7, 2015
    Single Audit Pilot Program Officials Push for Increased Participation by Device Makers
  • Oct 6, 2015
    FDA Orders Three Duodenoscope Makers To Conduct Postmarket Surveillance Studies
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.